Randomized controlled trial of testosterone in myotonic dystrophy

Neurology. 1989 Feb;39(2 Pt 1):219-22. doi: 10.1212/wnl.39.2.219.

Abstract

Because testosterone has an anabolic effect in myotonic dystrophy, we conducted a 12-month, randomized, double-blind therapeutic trial of testosterone enanthate (3 mg/kg/wk) in 40 men with myotonic dystrophy. We evaluated strength by manual muscle tests, quantitative myometry, pulmonary function, and quantitative functional assessment. A sustained, significant elevation of testosterone levels was produced but there was no effect on any measurement of muscle strength. Muscle mass as estimated by creatinine excretion and lean body mass (40K method) increased significantly. We conclude that testosterone does not improve strength in myotonic dystrophy despite increasing muscle mass.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acne Vulgaris / chemically induced
  • Adolescent
  • Adult
  • Aged
  • Clinical Trials as Topic
  • Double-Blind Method
  • Humans
  • Male
  • Middle Aged
  • Muscles / physiopathology
  • Myotonic Dystrophy / drug therapy*
  • Myotonic Dystrophy / physiopathology
  • Random Allocation
  • Testosterone / adverse effects
  • Testosterone / analogs & derivatives*
  • Testosterone / therapeutic use

Substances

  • Testosterone
  • testosterone enanthate